The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Shigehira Saji

Department of Surgery

Breast Oncology Unit

Tokyo Metropolitan Komagome Hospital

113-8677 Tokyo

Japan

[email]@wa2.so-net.ne.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Surgery, Breast Oncology Unit, Tokyo Metropolitan Komagome Hospital, 113-8677 Tokyo, Japan. 2002 - 2005
  • Department of Surgery, Komagome Hospital, Tokyo Metropolitan Medical Centre for Cancer and Infectious Diseases, 3-18-22 Honkomagome, Japan. 2002
  • 2nd Department of Surgery, Gifu University School of Medicine. 1999

References

  1. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Saji, S., Kawakami, M., Hayashi, S., Yoshida, N., Hirose, M., Horiguchi, S., Itoh, A., Funata, N., Schreiber, S.L., Yoshida, M., Toi, M. Oncogene (2005) [Pubmed]
  2. Novel sensitizing agents: potential contribution of COX-2 inhibitor for endocrine therapy of breast cancer. Saji, S., Hirose, M., Toi, M. Breast. Cancer (2004) [Pubmed]
  3. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor. Saji, S., Omoto, Y., Shimizu, C., Warner, M., Hayashi, Y., Horiguchi, S., Watanabe, T., Hayashi, S., Gustafsson, J.A., Toi, M. Cancer Res. (2002) [Pubmed]
  4. Clinical impact of assay of estrogen receptor beta cx in breast cancer. Saji, S., Omoto, Y., Shimizu, C., Horiguchi, S., Watanabe, T., Funata, N., Hayash, S., Gustafsson, J.A., Toi, M. Breast. Cancer (2002) [Pubmed]
  5. Aromatase inhibitors and other novel agents in breast cancer treatment. Saji, S., Toi, M. Expert. Opin. Emerg. Drugs (2002) [Pubmed]
  6. Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol. Saji, S., Nakashima, S., Hayashi, S., Toi, M., Saji, S., Nozawa, Y. Jpn. J. Cancer Res. (1999) [Pubmed]
 
WikiGenes - Universities